Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Biundo

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 9, 2017
Monitoring of motor and non-motor symptoms of Parkinson's disease through a mHealth platformJorge Cancela, Samanta Villanueva Mascato, Dimitrios Gatsios, et al.
Trials|September 16, 2018
Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trialAngelo Antonini, Giovanni Gentile, Manuela Giglio, et al.
Frontiers in Aging Neuroscience|March 20, 2026
Financial abilities in patients with Parkinson's disease and mild cognitive impairment: unveiling cognitive and neurofunctional correlates of basic and advanced financial skillsLaura Danesin, Giulia Pagnin, Lorenza Maistrello, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 16, 2026
Plasma p-tau217 Versus p-tau181 in Parkinson's Disease: Differential Associations with Alzheimer's Disease-Related Neurostructural Changes and Cognitive FunctionEleonora Fiorenzato, Simone Cauzzo, Giulia Musso, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 30, 2017
Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA studyRoberta Biundo, Luca Weis, Giovanni Abbruzzese, et al.
Frontiers in Neurology|September 2, 2025
Detecting amyloid and tau pathology in Parkinson's disease, 4R-tauopathies and control subjects with plasma pTau217Giulia Musso, Eleonora Fiorenzato, Valentina Misenti, et al.
Journal of Neurology|July 25, 2022
Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson's disease on levodopa/carbidopa intestinal gel infusionFederica Garrì, Francesco Paolo Russo, Tommaso Carrer, et al.
Journal of the Neurological Sciences|July 19, 2025
The role of blood-based biomarkers in Parkinsonian disorders, Alzheimer's disease and frontotemporal dementiaMarta Campagnolo, Eleonora Fiorenzato, Giulia Musso, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 27, 2024
Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating ScaleMichela Garon, Luca Weis, Antònia Siquier, et al.
Journal of Neurology|August 20, 2022
Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson's disease on levodopa/carbidopa intestinal gel infusionFederica Garrì, Francesco Paolo Russo, Tommaso Carrer, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 9, 2017
Monitoring of motor and non-motor symptoms of Parkinson's disease through a mHealth platformJorge Cancela, Samanta Villanueva Mascato, Dimitrios Gatsios, et al.
Trials|September 16, 2018
Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trialAngelo Antonini, Giovanni Gentile, Manuela Giglio, et al.
Frontiers in Aging Neuroscience|March 20, 2026
Financial abilities in patients with Parkinson's disease and mild cognitive impairment: unveiling cognitive and neurofunctional correlates of basic and advanced financial skillsLaura Danesin, Giulia Pagnin, Lorenza Maistrello, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 16, 2026
Plasma p-tau217 Versus p-tau181 in Parkinson's Disease: Differential Associations with Alzheimer's Disease-Related Neurostructural Changes and Cognitive FunctionEleonora Fiorenzato, Simone Cauzzo, Giulia Musso, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 30, 2017
Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA studyRoberta Biundo, Luca Weis, Giovanni Abbruzzese, et al.
Frontiers in Neurology|September 2, 2025
Detecting amyloid and tau pathology in Parkinson's disease, 4R-tauopathies and control subjects with plasma pTau217Giulia Musso, Eleonora Fiorenzato, Valentina Misenti, et al.
Journal of Neurology|July 25, 2022
Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson's disease on levodopa/carbidopa intestinal gel infusionFederica Garrì, Francesco Paolo Russo, Tommaso Carrer, et al.
Journal of the Neurological Sciences|July 19, 2025
The role of blood-based biomarkers in Parkinsonian disorders, Alzheimer's disease and frontotemporal dementiaMarta Campagnolo, Eleonora Fiorenzato, Giulia Musso, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 27, 2024
Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating ScaleMichela Garon, Luca Weis, Antònia Siquier, et al.
Journal of Neurology|August 20, 2022
Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson's disease on levodopa/carbidopa intestinal gel infusionFederica Garrì, Francesco Paolo Russo, Tommaso Carrer, et al.
Pageof 10